The Annual Male Breast Cancer Global Alliance Virtual Conference connects male survivors, their families, friends and supporters with top medical professionals and leading experts from the breast cancer research and oncology fields. The international conference, which focuses on increasing awareness and education about breast cancer in men, showcases the latest in research developments and clinical trials with an impressive line-up of speakers from leading organizations around the world.
José Pablo Leone, MD, Director, Program for Breast Cancer in Men
Assistant Professor of Medicine, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA
Dr. Leone’s clinical research focuses on brain metastases, male breast cancer and novel therapies in the treatment of breast cancer; he has co-authored 58 peer-reviewed articles and participated in 3 clinical trials in the past 15 years.
Kara N. Maxwell, MD, PhD, Assistant Professor of Medicine & Genetics, Perelman School of Medicine, University of Pennsylvania; Staff Physician, Corporal Michael Crescenz VA Medical Center, Philadelphia, PA
Dr. Maxwell is the Director of the Men and BRCA Program within the Basser Center for BRCA at Penn Medicine and also the Director of the Cancer Genetics program at the Philadelphia VA. Her laboratory studies mechanisms of tumor formation in patients with inherited forms of breast and prostate cancer.
Harikrishna Nakshatri, BVSc, PhD; Marion J. Morrison Professor of Breast Cancer Research, Professor of Surgery, Biochemistry and Molecular Biology, Indiana University School of Medicine; Associate Director of Education and Co-Leader, Breast Cancer Working Group, Indiana University Simon Comprehensive Cancer Center. Indianapolis, IN
Dr. Nakshatri studies the molecular drivers of therapy resistance in breast cancer. His group has developed various model systems to study breast cancer initiation and progression in both women and men.
Professor Nick Orr, PhD; School of Medicine, Dentistry and Biomedical Sciences, Patrick G. Johnston Centre for Cancer Research at Queen’s University, Belfast, Ireland
Professor Orr is the Lead Researcher of an international consortium working to uncover genes that lead to breast cancer in men. The consortium, known as MERGE, is focusing on discovering and characterizing new genetic risk factors for male breast cancer by analyzing DNA from 5,000 men.
Ben H. Park, MD, PhD; Benjamin F. Byrd, Jr. Chair in Oncology; Director, Vanderbilt-Ingram Cancer Center; Professor of Medicine, Vanderbilt University Medical Center in Nashville, TN
Dr. Park is an internationally-renowned physician, scientist, and breast cancer expert with a specialty in male breast cancer research and clinical care of men with breast cancer. He has published widely on the genetics of male breast cancer as well as reviews regarding the clinical management of men with this disease.
Kathryn Ruddy, MD, Professor of Oncology (with a specialty in male breast cancer) and Consultant for the Division of Medical Oncology at the Mayo Clinic in Rochester, MN
Dr. Ruddy is a medical oncologist who specializes in breast cancer patients. She has special expertise in male breast cancer and studies the long-term and late effects of cancer treatments, and how best to care for cancer survivors to enhance their quality of life and reduce symptoms.
Carolien Schröder, MD, PhD, Staff Member, Medical Oncology, Department, Antoni Van Leeuwenhoek-Netherlands Cancer Institute in Amsterdam, The Netherlands
Dr. Schröder’s research is focused on pre-clinical and clinical intervention strategies directed at the breast cancer microenvironment and metastases, early clinical trials with novel anticancer agents, and large-scale registration and translational trials for rare subgroups including male and inflammatory breast cancer.
Ander Urruticorchea, MD, PhD, Institute Scientific and General Manager, Onkologikoa Foundation, San Sebastián, Spain; Associate Professor, Faculty of Health Sciences, University of Deusto in Bilbao, Spain
Dr. Urruticorchea is Medical Oncology Specialist whose research focuses on molecular biology and the treatment of breast cancer, with a particular focus on endocrine resistance. He is Vice Chair of GEICAM (The Spanish Breast Cancer Group), where he co-leads the Spanish Registry of Male Breast Cancer.
ALL are welcome to attend our 2024 MBCGA Virtual Conference free of charge. However, your donation (no amount is too small!) will help us to continue increasing awareness and providing the most up-to-date information on breast cancer in men, advances in research and treatments, seek out opportunities for clinical trials, and advocate for treatment equity, on a global scale. Thank you for your support!
Thank you to our 2024 MBCGA Virtual Conference sponsors.
REGISTRATION FOR MBCGA 2024 VIRTUAL CONFERENCE
